Webcasts

Tue, Sep 27, 2022 2:00 PM EDT | 11am PT | 2pm ET | 7pm BST Many novel cell and gene therapies (CGTs) are now entering the commercialization stage but, as developers look to recoup investment and quickly deliver life-saving therapies to the patients that need them, they face a myriad of challenges. In this webinar, learn how advanced therapy medicinal product (ATMP) platforms, using single-use systems, are delivering streamlined, efficient and cost-effective manufacturing solutions in this dynamic sector.

Thursday, September 22nd, 2022 9:00am EDT|6:00am PDT|2:00pm BST|3:00pm CEST 2:00pm EDT|11:00am PDT|7:00pm BST|8:00pm CEST See how RapidFire automated size exclusion chromatography (SEC) combined with the power of ion mobility mass spectrometry (IM-MS) enables efficient biotherapeutic development.

Wed, Sep 21, 2022 2:00 PM EDT This webinar will review the key considerations and gaps in evaluating freeze/thaw solutions, examine the elements of a dedicated technology center to bridging these gaps and development risks, and explore successful case studies of a technology center optimizing processes and speed-to-market.

Tuesday, September 20, 2022 at 11 AM EST During chromatographic analysis of complex biotherapeutics, analytes may contain electron-rich functional groups, which have an affinity to metal surfaces and may cause issues such as poor peak shape. Join our webinar to learn how Waters addresses these challenges.

Thursday, September 15th, 2022 at 4pm CEST | 3pm BST | 10am EDT Extra cellular vesicles and especially exosomes have recently gained favor for therapeutic medicine development due to possessing structures that can be modified to conveniently deliver payloads, such as specific proteins, genetic lipids, and genetic materials including messenger RNA (mRNA, and genomic DNA (gDNA) from their progenitor cell. Most recently, there is increasing interest in the therapeutic potential of exosomes produced by Mesenchymal Stem Cells (MSCs). Stirred-tank bioreactors offer the possibility to tightly control and monitor the production of exosomes, as well as the scalability, to produce increasing amounts. However, the cultivation of stem cells in stirred-tank bioreactors requires profound knowledge and precise control of the process.

Wednesday, September 14, 2022 Morning Session: 9am EDT | 6am PDT | 2pm BST| 3pm CEST Afternoon Session: 1pm EDT | 10am PDT | 6pm BST | 7pm CEST Are your analytical methods keeping up with the pace of new biotherapeutic drug modalities? Attend this symposium to ensure success!

Tue, Sep 13, 2022 10:00 AM EDT Discover how AstraZeneca uses Genedata Imagence—an enterprise-scale, deep learning-based software solution for image analysis—for projects spanning different disease areas and stages of R&D

Thu, Sep 8, 2022 11am EST | 8am PST | 4pm BST | 5pm CEST Digitalization & leveraging real-time data are key for biopharma process improvement. Insilico models and soft-sensors boost biopharma performance to unprecedented levels.

Tue, Aug 23, 2022 11:00 AM EDT Advanced PAT tools such as RT–MALS offer in-depth characterization of biological molecules and nanoparticles to help optimize manufacturing processes.

Wed, Aug 17, 2022 2:00 PM EDT Recent advances in both oncology drug development and novel digital technologies provide a ripe opportunity to enhance the clinical trial process. Join Colin Weller and Musaddiq Khan from Medable as they discuss the key considerations around these innovations.

Tue, Aug 23, 2022 11:00 AM EDT Staying ahead of coming regulatory concerns surrounding particulates in cell and gene therapy manufacturing. Do you know how many particles are in your biomanufacturing process and what to do to reduce them?

Thursday, June 30, 2022 at 11am PST | 1pm CST | 2pm EST As CRISPR based gene editing progresses from research to therapeutic applications, there is a growing need for high quality GMP grade materials, including the Cas9 protein and supporting instruments, and to minimize off target events. This webinar will discuss the development process of a GMP-manufactured Cas9 protein along with causes of off target events and how to minimize risk with high fidelity Cas9 protein.

Now Available On Demand!

Thursday, June 23, 2022 at 10am ET | 3pm BST | 4pm CEST Join us on June 23 to learn about QC Analysis of Oligonucleotide Therapeutics. One Platform Method for Determining Identity, Purity, and Quantity.

Now Available On Demand Learn about recent innovations and trends in the purification of monoclonal antibodies (mAbs) in this free, online virtual symposium. Industry experts will present insights on topics such as supply chain security, innovations in resin design and maximizing productivity in-process, as well as field questions from the audience.

Monday June 20th, 2022 at 11am ET | 10am CT | 8am PT Getinge Applikon invites you to get a glimpse of a process for stainless steel bioreactor manufacturing and verification. Walk through the halls of our manufacturing facility and see how commercial scale stainless steel vessels take shape, get to know Getinge engineers, visit manufacturing stages, and hear how the experts collaborate to configure and fabricate a system for manufacturing.

Wednesday, May 18th, 2022 at 3pm BST | 10am EDT | 4pm CEST | 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.

Tuesday, May 17, 2022 at 9 AM EDT|6am PDT|2pm BST|3pm CEST Tuesday, May 17, 2022 at 2 PM EDT|11am PDT|7pm BST|8pm CEST Increase productivity and reduce costs for mAb purification. Learn how multi-column continuous chromatography can improve your mAb purification workflow.

Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.

Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..

Tuesday, April 12th 2022 at 10 am EDT | 7 am PDT | 3 pm GMT Freezing and thawing biotherapeutics requires experienced leadership to navigate material and instrument selection as well as quality, space, regulatory and other considerations in creating a new cold-chain ecosystem. This webinar discusses the design of processes in partnership with a uniquely resourced freeze/thaw technology center.

Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.

Thursday, March 24, 2022 at 11am EST | 10am CST | 8am PST Advancing size-exclusion chromatography through recent developments in particle technology and hydrophilic surfaces.

March 17th 2022 at 10am EST | 9am CST | 3pm GMT | 4pm CET • Automating and Streamlining MS-Based Developability Assessment of Biotherapeutics• Automating MS-Based Biotherapeutic Characterization Workflows for Developability

Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.

This webcast is now available on demand! The delicate dance between strategic initiatives of continuous improvement and maintaining daily operational discipline amid the significant challenges placed on global supply chains by COVID-19. This webcast will discuss the risk-based approach used to minimize procurement risk and optimize material readiness.

Monday, February, 28, 2022 at 9am EST | 8am CST | 6am PST Realizing benefits from Smart Manufacturing technologies doesn’t have to be long-term prospect. Solve today’s manufacturing challenges while laying the foundation for tomorrow’s plant.

Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.

Tuesday, February 8th, 2022 at 9am EST | 3pm CET | 2pm GMT and 2pm EST | 11am PST | 7pm GMT Approaches and lessons learned on developing an HPLC methodology to cover a complex and broad range of polar analytes: the complete cellular pool of nucleosides and nucleotides plus our drug candidates and associated prodrugs. The utility of PEEK-lined columns and newer HILIC-Z column phases is highlighted in this anecdote of HPLC methodology development.

Wednesday, February 8th at 11am EST | 10am CST | 8am PST Industry shifts in container closure integrity (CCI) are driving the next generation of quality control solutions. Understanding the physics behind the technologies and their relation to your application will carve a path of successful CCI assurance.